beyaz
(WILJGCROUAPWLS-KBGXLKHCSA-L)
Structure
- SMILES
- O=C1CC[C@]2(C(=C1)[C@@H]1C[C@@H]1[C@@H]1[C@@H]2CC[C@]2([C@H]1[C@@H]1C[C@@H]1[C@]12CCC(=O)O1)C)C.[O-]C(=O)CC[C@@H](C(=O)[O-])NC(=O)c1ccc(cc1)NC[C@H]1CNc2c(N1C)c(=O)[nH]c(n2)N.C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O.[Ca+2]
- Molecular Formula:
- C64H77CaN7O11
- Molecular Weight:
- 1160.410
- Log P:
- 6.2395
- Hydrogen Bond Acceptor:
- 17
- Hydrogen Bond Donor:
- 7
- TPSA:
- 292.26
- CAS Number(s):
- 914956-24-4
Synonym(s)
1.
beyaz
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug dose omission | FAERS: 106 | US FAERS | |
| 2 | No adverse event | FAERS: 102 | US FAERS | |
| 3 | Pulmonary Embolism | FAERS: 84 | US FAERS | |
| 4 | Metrorrhagia | FAERS: 75 | US FAERS | |
| 5 | Nausea | FAERS: 51 | US FAERS | |
| 6 | Deep Vein Thrombosis | FAERS: 48 | US FAERS | |
| 7 | Headache | FAERS: 41 | US FAERS | |
| 8 | Menorrhagia | FAERS: 40 | US FAERS | |
| 9 | Vomiting | FAERS: 36 | US FAERS | |
| 10 | Acne | FAERS: 31 | US FAERS | |
| 11 | Fatigue | FAERS: 28 | US FAERS | |
| 12 | Pain | FAERS: 28 | US FAERS | |
| 13 | Thrombosis | FAERS: 25 | US FAERS | |
| 14 | Inappropriate schedule of drug administration | FAERS: 24 | US FAERS | |
| 15 | Emotional distress | FAERS: 19 | US FAERS | |
| 16 | Abdominal Pain | FAERS: 18 | US FAERS | |
| 17 | Product use issue | FAERS: 18 | US FAERS | |
| 18 | Anxiety | FAERS: 17 | US FAERS | |
| 19 | Pregnancy on oral contraceptive | FAERS: 16 | US FAERS | |
| 20 | Abnormal withdrawal bleeding | FAERS: 15 | US FAERS | |
| 21 | Cerebrovascular accident | FAERS: 15 | US FAERS | |
| 22 | Chest Pain | FAERS: 14 | US FAERS | |
| 23 | Malaise | FAERS: 14 | US FAERS | |
| 24 | Breast tenderness | FAERS: 13 | US FAERS | |
| 25 | Mood swings | FAERS: 12 | US FAERS | |
| 26 | Dizziness | FAERS: 10 | US FAERS | |
| 27 | Feeling abnormal | FAERS: 10 | US FAERS | |
| 28 | Back Pain | FAERS: 9 | US FAERS | |
| 29 | Extra dose administered | FAERS: 9 | US FAERS | |
| 30 | Asthenia | FAERS: 8 | US FAERS | |
| 31 | Premenstrual syndrome | FAERS: 8 | US FAERS | |
| 32 | Urinary tract infection | FAERS: 8 | US FAERS | |
| 33 | Urticaria | FAERS: 8 | US FAERS | |
| 34 | Alopecia | FAERS: 7 | US FAERS | |
| 35 | Arthralgia | FAERS: 7 | US FAERS | |
| 36 | Drug administration error | FAERS: 7 | US FAERS | |
| 37 | Emotional disorder | FAERS: 7 | US FAERS | |
| 38 | Hormone level abnormal | FAERS: 6 | US FAERS | |
| 39 | Incorrect dose administered | FAERS: 6 | US FAERS | |
| 40 | Palpitations | FAERS: 6 | US FAERS | |
| 41 | Pulmonary thrombosis | FAERS: 6 | US FAERS | |
| 42 | Swelling | FAERS: 6 | US FAERS | |
| 43 | Vaginal Discharge | FAERS: 6 | US FAERS | |
| 44 | Adverse event | FAERS: 5 | US FAERS | |
| 45 | Cholelithiasis | FAERS: 5 | US FAERS | |
| 46 | Crying | FAERS: 5 | US FAERS | |
| 47 | Hypersensitivity | FAERS: 5 | US FAERS | |
| 48 | Pruritus | FAERS: 5 | US FAERS | |
| 49 | Abdominal discomfort | FAERS: 4 | US FAERS | |
| 50 | Anhedonia | FAERS: 4 | US FAERS | |
| 51 | Cerebral Thrombosis | FAERS: 4 | US FAERS | |
| 52 | Drug ineffective | FAERS: 4 | US FAERS | |
| 53 | Dyspepsia | FAERS: 4 | US FAERS | |
| 54 | Incorrect product storage | FAERS: 4 | US FAERS | |
| 55 | Medication Error | FAERS: 4 | US FAERS | |
| 56 | Neck Pain | FAERS: 4 | US FAERS | |
| 57 | Night sweats | FAERS: 4 | US FAERS | |
| 58 | Product use in unapproved indication | FAERS: 4 | US FAERS | |
| 59 | Sinusitis | FAERS: 4 | US FAERS | |
| 60 | Weight decreased | FAERS: 4 | US FAERS | |
| 61 | Abnormal weight gain | FAERS: 3 | US FAERS | |
| 62 | Activities of daily living impaired | FAERS: 3 | US FAERS | |
| 63 | Anger | FAERS: 3 | US FAERS | |
| 64 | Chest discomfort | FAERS: 3 | US FAERS | |
| 65 | Coital bleeding | FAERS: 3 | US FAERS | |
| 66 | Depressed mood | FAERS: 3 | US FAERS | |
| 67 | Drug ineffective for unapproved indication | FAERS: 3 | US FAERS | |
| 68 | Dysgeusia | FAERS: 3 | US FAERS | |
| 69 | Expired drug administered | FAERS: 3 | US FAERS | |
| 70 | Flatulence | FAERS: 3 | US FAERS | |
| 71 | General physical health deterioration | FAERS: 3 | US FAERS | |
| 72 | Lethargy | FAERS: 3 | US FAERS | |
| 73 | Lip swelling | FAERS: 3 | US FAERS | |
| 74 | Musculoskeletal chest pain | FAERS: 3 | US FAERS | |
| 75 | Pelvic Pain | FAERS: 3 | US FAERS | |
| 76 | Pre-existing condition improved | FAERS: 3 | US FAERS | |
| 77 | Stress | FAERS: 3 | US FAERS | |
| 78 | Therapeutic response unexpected | FAERS: 3 | US FAERS | |
| 79 | Tremor | FAERS: 3 | US FAERS | |
| 80 | Visual Impairment | FAERS: 3 | US FAERS | |
| 81 | Amnesia | FAERS: 2 | US FAERS | |
| 82 | Aphasia | FAERS: 2 | US FAERS | |
| 83 | Blood cholesterol increased | FAERS: 2 | US FAERS | |
| 84 | Blood folate increased | FAERS: 2 | US FAERS | |
| 85 | Blood potassium decreased | FAERS: 2 | US FAERS | |
| 86 | Chromaturia | FAERS: 2 | US FAERS | |
| 87 | Drug effective for unapproved indication | FAERS: 2 | US FAERS | |
| 88 | Endometrial disorder | FAERS: 2 | US FAERS | |
| 89 | Expired product administered | FAERS: 2 | US FAERS | |
| 90 | Exposure during breast feeding | FAERS: 2 | US FAERS | |
| 91 | Hyperphagia | FAERS: 2 | US FAERS | |
| 92 | Hypophagia | FAERS: 2 | US FAERS | |
| 93 | Impaired work ability | FAERS: 2 | US FAERS | |
| 94 | Incorrect drug administration duration | FAERS: 2 | US FAERS | |
| 95 | Intentional product misuse | FAERS: 2 | US FAERS | |
| 96 | Mental status changes | FAERS: 2 | US FAERS | |
| 97 | Multiple allergies | FAERS: 2 | US FAERS | |
| 98 | Musculoskeletal Pain | FAERS: 2 | US FAERS | |
| 99 | Myocardial Infarction | FAERS: 2 | US FAERS | |
| 100 | Photophobia | FAERS: 2 | US FAERS | |
| 101 | Pleurisy | FAERS: 2 | US FAERS | |
| 102 | Product quality issue | FAERS: 2 | US FAERS | |
| 103 | Pulmonary Infarction | FAERS: 2 | US FAERS | |
| 104 | Rash erythematous | FAERS: 2 | US FAERS | |
| 105 | Retching | FAERS: 2 | US FAERS | |
| 106 | Toxic Shock Syndrome | FAERS: 2 | US FAERS | |
| 107 | Unresponsive to stimuli | FAERS: 2 | US FAERS | |
| 108 | Vertigo | FAERS: 2 | US FAERS | |
| 109 | Vulvovaginal pain | FAERS: 2 | US FAERS | |
| 110 | Abasia | FAERS: 1 | US FAERS | |
| 111 | Accidental exposure to product by child | FAERS: 1 | US FAERS | |
| 112 | Adnexa uteri pain | FAERS: 1 | US FAERS | |
| 113 | Aneurysm | FAERS: 1 | US FAERS | |
| 114 | Angioedema | FAERS: 1 | US FAERS | |
| 115 | Antiphospholipid Syndrome | FAERS: 1 | US FAERS | |
| 116 | Asthma | FAERS: 1 | US FAERS | |
| 117 | Basilar artery thrombosis | FAERS: 1 | US FAERS | |
| 118 | Blood follicle stimulating hormone increased | FAERS: 1 | US FAERS | |
| 119 | Blood potassium increased | FAERS: 1 | US FAERS | |
| 120 | Blood testosterone decreased | FAERS: 1 | US FAERS | |
| 121 | Brain Death | FAERS: 1 | US FAERS | |
| 122 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 123 | Cardiac discomfort | FAERS: 1 | US FAERS | |
| 124 | Cheilitis | FAERS: 1 | US FAERS | |
| 125 | Chloasma | FAERS: 1 | US FAERS | |
| 126 | Choking | FAERS: 1 | US FAERS | |
| 127 | Cold sweat | FAERS: 1 | US FAERS | |
| 128 | Constipation | FAERS: 1 | US FAERS | |
| 129 | Contact lens intolerance | FAERS: 1 | US FAERS | |
| 130 | Dehydroepiandrosterone decreased | FAERS: 1 | US FAERS | |
| 131 | Diplopia | FAERS: 1 | US FAERS | |
| 132 | Discomfort | FAERS: 1 | US FAERS | |
| 133 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 134 | Drug withdrawal syndrome | FAERS: 1 | US FAERS | |
| 135 | Dysarthria | FAERS: 1 | US FAERS | |
| 136 | Dysuria | FAERS: 1 | US FAERS | |
| 137 | Ear discomfort | FAERS: 1 | US FAERS | |
| 138 | Eczema | FAERS: 1 | US FAERS | |
| 139 | Electroencephalogram abnormal | FAERS: 1 | US FAERS | |
| 140 | Endometriosis | FAERS: 1 | US FAERS | |
| 141 | Epistaxis | FAERS: 1 | US FAERS | |
| 142 | Eructation | FAERS: 1 | US FAERS | |
| 143 | Erythema Nodosum | FAERS: 1 | US FAERS | |
| 144 | Eye irritation | FAERS: 1 | US FAERS | |
| 145 | Eye pain | FAERS: 1 | US FAERS | |
| 146 | Flank Pain | FAERS: 1 | US FAERS | |
| 147 | Full blood count increased | FAERS: 1 | US FAERS | |
| 148 | Gait deviation | FAERS: 1 | US FAERS | |
| 149 | General physical condition abnormal | FAERS: 1 | US FAERS | |
| 150 | Head deformity | FAERS: 1 | US FAERS | |
| 151 | Hemiplegia | FAERS: 1 | US FAERS | |
| 152 | Hunger | FAERS: 1 | US FAERS | |
| 153 | Hyperacusis | FAERS: 1 | US FAERS | |
| 154 | Hypotension | FAERS: 1 | US FAERS | |
| 155 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 156 | Infectious Mononucleosis | FAERS: 1 | US FAERS | |
| 157 | Influenza | FAERS: 1 | US FAERS | |
| 158 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 159 | Intentional self-injury | FAERS: 1 | US FAERS | |
| 160 | Medication residue present | FAERS: 1 | US FAERS | |
| 161 | Muscle tightness | FAERS: 1 | US FAERS | |
| 162 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 163 | Ocular icterus | FAERS: 1 | US FAERS | |
| 164 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 165 | Pelvic venous thrombosis | FAERS: 1 | US FAERS | |
| 166 | Peripheral embolism | FAERS: 1 | US FAERS | |
| 167 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 168 | Pharyngitis | FAERS: 1 | US FAERS | |
| 169 | Phonophobia | FAERS: 1 | US FAERS | |
| 170 | Pneumonia | FAERS: 1 | US FAERS | |
| 171 | Portal Vein Thrombosis | FAERS: 1 | US FAERS | |
| 172 | Pregnancy | FAERS: 1 | US FAERS | |
| 173 | Product dose omission | FAERS: 1 | US FAERS | |
| 174 | Product packaging issue | FAERS: 1 | US FAERS | |
| 175 | Product packaging quantity issue | FAERS: 1 | US FAERS | |
| 176 | Product storage error | FAERS: 1 | US FAERS | |
| 177 | Product substitution issue | FAERS: 1 | US FAERS | |
| 178 | Progesterone decreased | FAERS: 1 | US FAERS | |
| 179 | Psychological Trauma | FAERS: 1 | US FAERS | |
| 180 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 181 | Retinal vascular thrombosis | FAERS: 1 | US FAERS | |
| 182 | Streptococcus test positive | FAERS: 1 | US FAERS | |
| 183 | Subclavian artery thrombosis | FAERS: 1 | US FAERS | |
| 184 | Suicide attempt | FAERS: 1 | US FAERS | |
| 185 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 186 | Suspected counterfeit product | FAERS: 1 | US FAERS | |
| 187 | Syncope | FAERS: 1 | US FAERS | |
| 188 | Tachycardia | FAERS: 1 | US FAERS | |
| 189 | Therapeutic product ineffective | FAERS: 1 | US FAERS | |
| 190 | Therapeutic response changed | FAERS: 1 | US FAERS | |
| 191 | Throat irritation | FAERS: 1 | US FAERS | |
| 192 | Thrombophlebitis | FAERS: 1 | US FAERS | |
| 193 | Thrombotic stroke | FAERS: 1 | US FAERS | |
| 194 | Unevaluable event | FAERS: 1 | US FAERS | |
| 195 | Vestibulitis | FAERS: 1 | US FAERS | |
| 196 | Vulvovaginal discomfort | FAERS: 1 | US FAERS | |
| 197 | Vulvovaginal dryness | FAERS: 1 | US FAERS | |
| 198 | jaundice | FAERS: 1 | US FAERS | |
| 199 | nervous system disorder | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.